European Myocardial Infarction Project—Free Radicals - EMIP-FR

Description:

The EMIP-FR trial was a randomized, double-blinded, placebo-controlled trial designed to assess whether treatment with trimetazidine, an agent that reduces oxidative stress and reperfusion injury in experimental models, would improve outcomes in patients with symptoms suggestive of acute myocardial infarction (MI).